Dosage form: tablet, delayed release
Drug class:Macrolides
Medically reviewed by Drugs.com. Last updated on Sep 1, 2021.
On This Page
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Erythromycin Delayed-Release Tablets and other antibacterial drugs, Erythromycin Delayed-Release Tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
Erythromycin Delayed-Release Tablet Description
Erythromycin Delayed-Release Tablets are an antibacterial product containing erythromycin base in a specially enteric-coated tablet. The coating protects the antibiotic from the inactivating effects of gastric acidity and permits efficient absorption of the antibiotic in the small intestine. Erythromycin Delayed-Release Tablets for oral administration are available in two dosage strengths, each white to off white oval tablet containing 250 mg, or 500 mg of erythromycin as the free base. Erythromycin Delayed-Release Tablets comply with USP Dissolution Test 1.
Erythromycin is produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the ma..
